Table 1.

Clinical and Biochemical Characteristics of the Study Participants^*

	Insulin Sensitive HOMA < 2.4 (N= 10)	Insulin Resistant HOMA ≥ 2.4 (N= 10)	P Value†
Age - yr			0.2
Mean	39 ± 6	43 ± 9
Range	31-54	33-57
Female sex - no. (%)	8 (80)	6 (60)	0.4‡
Weight (kg)			0.2
Mean	137 ± 11	149 ± 18
Range	119-177	120-188
BMI§			0.7
Mean	48 ± 3	49 ± 7
Range	46-55	39-60
Total cholesterol (mg/dL)**			0.9
Mean	176 ± 27	179 ± 50
Range	115-211	111-276
LDL cholesterol (mg/dL)**			0.6
Mean	109 ± 15	101 ± 45
Range	76-127	45-190
HDL cholesterol (mg/dL)**
Mean	44 ± 5	42 ± 9	0.5
Range	38-52	30-56
Triglycerides (mg/dL)**			0.2
Mean	129 ± 33	166 ± 74
Range	94-188	74-274
Lipid lowering therapy - no. (%)	1 (10)	3 (30)	0.3‡
Fasting glucose (mg/dL)			0.02
Mean	88 ± 9	101 ± 12
Range	75-100	82-127
Fasting insulin (mIU/mL)			<0.001
Mean	9 ± 4	24 ± 7
Range	4-14	16-36
HOMA2			<0.001
Mean	1.3 ± 0.5	3.6 ± 5.3
Range	0.6-2.1	2.4-6.7

^*Plus-minus values are mean ± SD.

^†P values were estimated using Student's t-test unless otherwise specified.

^‡P-value was estimated using Fisher's exact test.

^§The body-mass-index (BMI) is the weight in kilograms divided by the square of the height in meters.

^**Data was not available for three patients (1 IS, 2 IR)